Epidermodysplasia verruciformis: What's new?

Journal of the European Academy of Dermatology and Venereology

Volumn 17, Issue 4, 2003, Pages 381-382

  Jablonska, S ^a   Majewski, S ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYCLOSPORIN A;

AUTOIMMUNITY; CANCER GROWTH; CLINICAL FEATURE; DISEASE ASSOCIATION; DRUG TARGETING; EDITORIAL; EPIDERMODYSPLASIA VERRUCIFORMIS; GENETIC DISORDER; HUMAN; MALIGNANT TRANSFORMATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SKIN CANCER; SKIN DEFECT; VERRUCA VULGARIS; VIRUS DETECTION; WART VIRUS;

CELL TRANSFORMATION, NEOPLASTIC; CHRONIC DISEASE; EPIDERMODYSPLASIA VERRUCIFORMIS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; PAPILLOMAVIRIDAE; PRECANCEROUS CONDITIONS; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SKIN NEOPLASMS;

EID: 0038267401     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-3083.2003.00702.x     Document Type: Editorial

References (16)

1. Roncalli W, De Oliveira WRP, Neto CF, Rady PL et al. Aspects of epidermodysplasia verruciformis. J Eur Acad Derm Venereol 2003; 17: 382-386.
2. zur Hausen H. Papillomavirus infections: a major cause of human cancers. Biochem Biophys Acta 1996; 1288: F55-F78.
3. Majewski S, Jablonska S, Orth G. Epidermodysplasia verruciformis. Immunological and nonimmunological surveillance mechanisms: role in tumor progression. Clin Dermatol 1997; 15: 321-334.
4. Orth G, Jablonska S, Favre M et al. Characterization of two types of human papillomaviruses in lesions of epidermodysplasia verruciformis. Proc Nat Acad Sci USA, 1978; 75: 1537-1541.
5. Orth G. Epidermodysplasia verruciformis. In: Salzman HP, Howley PM, eds. The Papillomaviruses. New York: Plenum Press, 1987: 199-243.
6. Majewski S, Jablonska S. Epidermodysplasia verruciformis as a model of human papillomavirus-induced genetic cancer of the skin. Arch Dermatol 1995; 131: 1312-1318.
7. de Villiers EM, Lavergne D, McLaren K et al. Prevailing papillomavirus types in non-melanoma carcinomas of the skin in renal allograft recipients. Int J Cancer 1997; 73: 356-361.
8. Jablonska S, Majewski S, Obalek S. Skin tumors associated with immunosuppression. In: Chu AC, Edelson RL, eds. Malignant Tumors of the Skin. London: Edward Arnold, 1999: 302-313.
9. Astori G, Lavergne D, Benton C et al. Human papillomaviruses are commonly found in normal skin of immunocompetent hosts. J Invest Dermatol 1998; 110: 752-755.
10. Harwood C, Surenhern T, McGregor JM et al. Human papillomaviruses infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals. J Med Virol 2000; 61: 289-297.
11. Favre M, Orth G, Majewski S et al. Psoriasis: a possible reservoir for human papillomavirus type 5, the virus associated with skin carcinomas of epidermodysplasia verruciformis. J Invest Dermatol 1998; 110: 311-317.
12. Majewski S, Jablonska S, Favre M et al. Papillomavirus and autoimmunity in psoriasis. Immunol Today 1999; 20: 475-476.
13. Majewski S, Jablonska S. Do epidermodysplasia verruciformis human papillomaviruses contribute to malignant and benign epidermal proliferations? Arch Dermatol 2002; 138: 649-654.
14. Krueger JS. Alefacept-induced selective reductions in memory T-cell subsets correlate with improvements in psoriasis activity. In: From Pathogenesis to Practice: Selectively Targeting T Cell to Improve Clinical Outcomes in Psoriasis. SID Meeting Los Angeles, May 2002.
15. Ramoz N, Rueda LA, Bouadjar B et al. A susceptibility locus for epidermodysplasia verruciformis, an abnormal predisposition to infection with the oncogenic human papillomavirus type 5, maps to chromosome 17qter in a region containing a psoriasis locus. J Invest Dermatol 1999; 112: 259-263.
16. Ramoz N, Taieb A, Rueda LA et al. Evidence for a nonallelic heterogeneity of epidermodysplasia verruciformis with two susceptibility loci mapped to chromosome regions 2p21-p24 and 17q25. J Invest Dermatol 2000; 114: 1148-1153.